| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 22,385 | 31,122 | 45,758 | | Cost of Revenue | 15,141 | 23,354 | 33,496 | | | Gross Profit | 7,244 | 7,768 | 12,262 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 7,853 | 13,212 | 12,875 | | Non Recurring | 46 | (1,230) | 2,981 | | Others | 610 | 696 | 864 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,265) | (4,910) | (4,459) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 27 | 92 |
-
| | Earnings Before Interest And Taxes | (1,238) | (4,818) | (4,459) | | Interest Expense | 369 | 552 | 466 | | Income Before Tax | (1,607) | (5,369) | (4,925) | | Income Tax Expense | 230 | 39 | (1,436) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,837) | (5,408) | (3,489) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,837) | (5,408) | (3,489) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,837) | ($5,408) | ($3,489) |
|
0.29% Nasdaq 
0.04 (8.70%) 
Income Statement
